CLINICAL_TRIALS
trial_result
· 2016-05-02
Clinical Trial Update: A Study of Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
Phase 2 study evaluating Rituximab (MabThera) in chronic lymphocytic leukemia has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Lymphocytic Leukemia, Chronic | Phase 2 | Status: COMPLETED | Results posted: 2016-05-02